These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 9487636)

  • 21. Recurrence of primary sclerosing cholangitis, primary biliary cholangitis and auto-immune hepatitis after liver transplantation.
    Visseren T; Darwish Murad S
    Best Pract Res Clin Gastroenterol; 2017 Apr; 31(2):187-198. PubMed ID: 28624107
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary biliary cirrhosis and primary sclerosing cholangitis.
    Angulo P; Lindor KD
    Clin Liver Dis; 1999 Aug; 3(3):529-70. PubMed ID: 11291238
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autoimmune diseases of the liver.
    Manns MP
    Clin Lab Med; 1992 Mar; 12(1):25-40. PubMed ID: 1563239
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brazilian society of hepatology recommendations for the diagnosis and management of autoimmune diseases of the liver.
    Bittencourt PL; Cançado EL; Couto CA; Levy C; Porta G; Silva AE; Terrabuio DR; ; Carvalho Filho RJ; Chaves DM; Miura IK; Codes L; Faria LC; Evangelista AS; Farias AQ; Gonçalves LL; Harriz M; Lopes Neto EP; Luz GO; Oliveira P; Oliveira EM; Schiavon JL; Seva-Pereira T; Parise ER
    Arq Gastroenterol; 2015 Dec; 52 Suppl 1():15-46. PubMed ID: 26959804
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Guidelines for therapy of autoimmune liver disease.
    Ishibashi H; Komori A; Shimoda S; Gershwin ME
    Semin Liver Dis; 2007 May; 27(2):214-26. PubMed ID: 17520519
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic Potential of IL-17-Mediated Signaling Pathway in Autoimmune Liver Diseases.
    Zhang H; Bernuzzi F; Lleo A; Ma X; Invernizzi P
    Mediators Inflamm; 2015; 2015():436450. PubMed ID: 26146463
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Indications for immunosuppressive therapy in hepatology].
    Husa P; Chalupa P
    Vnitr Lek; 1998 Nov; 44(11):665-70. PubMed ID: 10422508
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autoimmune hepatitis overlapping with primary sclerosing cholangitis in five cases.
    McNair AN; Moloney M; Portmann BC; Williams R; McFarlane IG
    Am J Gastroenterol; 1998 May; 93(5):777-84. PubMed ID: 9625127
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High prevalence of small duct primary sclerosing cholangitis among patients with overlapping autoimmune hepatitis and primary sclerosing cholangitis.
    Olsson R; Glaumann H; Almer S; Broomé U; Lebrun B; Bergquist A; Björnsson E; Prytz H; Danielsson A; Lindgren S
    Eur J Intern Med; 2009 Mar; 20(2):190-6. PubMed ID: 19327611
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Autoimmune liver diseases. Part I].
    Ziółkowski J; Zagozdzon R; Paczek L
    Przegl Lek; 1999; 56(5):385-9. PubMed ID: 10554578
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urinary tract infection as a risk factor for autoimmune liver disease: from bench to bedside.
    Smyk DS; Bogdanos DP; Kriese S; Billinis C; Burroughs AK; Rigopoulou EI
    Clin Res Hepatol Gastroenterol; 2012 Apr; 36(2):110-21. PubMed ID: 21907008
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autoimmune diseases of the liver and biliary tract and overlap syndromes in childhood.
    Maggiore G; Riva S; Sciveres M
    Minerva Gastroenterol Dietol; 2009 Mar; 55(1):53-70. PubMed ID: 19212308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. UPDATE OF THE BRAZILIAN SOCIETY OF HEPATOLOGY RECOMMENDATIONS FOR DIAGNOSIS AND MANAGEMENT OF AUTOIMMUNE DISEASES OF THE LIVER.
    Couto CA; Terrabuio DRB; Cançado ELR; Porta G; Levy C; Silva AEB; Bittencourt PL; ; Carvalho Filho RJ; Chaves DM; Miura IK; Codes L; Faria LC; Evangelista AS; Farias AQ; Gonçalves LL; Harriz M; Lopes EPA; Luz GO; Oliveira PMC; Oliveira EMG; Schiavon JLN; Sevá-Pereira T
    Arq Gastroenterol; 2019 Aug; 56(2):232-241. PubMed ID: 31460591
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary sclerosing cholangitis.
    Geonzon-Gonzales MR
    Gastroenterol Nurs; 2007; 30(2):102-5; quiz 105-7. PubMed ID: 17440311
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cholestasis: therapeutic options].
    Beuers U; Oswald M
    Ther Umsch; 1998 Feb; 55(2):97-103. PubMed ID: 9545851
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autoimmune liver diseases.
    Bylund DJ; McHutchison J
    Clin Lab Med; 1997 Sep; 17(3):483-97. PubMed ID: 9316770
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study.
    Gregorio GV; Portmann B; Karani J; Harrison P; Donaldson PT; Vergani D; Mieli-Vergani G
    Hepatology; 2001 Mar; 33(3):544-53. PubMed ID: 11230733
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnosis and management of the overlap syndromes of autoimmune hepatitis.
    Czaja AJ
    Can J Gastroenterol; 2013 Jul; 27(7):417-23. PubMed ID: 23862175
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autoimmune Hepatitis and PSC Connection.
    Vergani D; Mieli-Vergani G
    Clin Liver Dis; 2008 Feb; 12(1):187-202, x. PubMed ID: 18242504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sclerosing cholangitis.
    MacFaul GR; Chapman RW
    Curr Opin Gastroenterol; 2006 May; 22(3):288-93. PubMed ID: 16550044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.